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Secondary tumours of the hyoid bone and thyroid cartilage are 
extremely rare. Primary malignancies that frequently metastasize 
to the hyoid bone and/or the thyroid cartilage arise from the 
adjacent tissues, e.g. the larynx, the vallecula and pyriform 
sinus (1). Only a few cases of the hyoid bone metastasis from 
distant primary malignancies, such as renal cell carcinoma 
and hepatocellular carcinoma, had been reported to date (2). 
Similarly, metastases to the thyroid cartilage were occasionally 
described in patients with hepatocellular carcinoma and lung 
adenocarcinoma (3,4). In this paper, we present a rare case of the 
hyoid bone and thyroid cartilage metastases in a patient treated 
for sigmoid colon adenocarcinoma. 
CASE PRESENTATION
A 63-year-old male patient was admitted to the hospital due to 
repeated episodes of abdominal pain and rectal bleeding. Initial 
workup included colonoscopy, which revealed an ulcerated mass 
in the sigmoid colon. Results of the biopsy were consistent with 
an adenocarcinoma. Serum levels of carcinoembryonic antigen 
(CEA) (89 ng/mL) and cancer antigen 19-9 (CA 19-9) (326.7 U/
mL) were elevated. Contrast-enhanced computerized tomography 
(CT) (Siemens Somatom Sensation 16, Munich, Germany) 
of the abdomen and pelvis showed presence of mesenteric 
lymphadenopathies and hypodense lesions in liver segments III, 
IV and V. The lesions in the liver were highly suggestive for 
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Background: Secondary tumours of the hyoid bone and 
thyroid cartilage are extremely rare. In this paper, we 
present a case of the hyoid bone and thyroid cartilage 
metastases in a patient treated for sigmoid colon 
adenocarcinoma.
Case Report: Four years after sigmoid colon 
adenocarcinoma was diagnosed and treated with surgery 
and chemotherapy, the patient developed bone metastases 
in the left sacroiliac joint and right proximal humerus. 
Although the patient did not complain of any related 
symptoms, in a bone scintigraphy the accumulation of 
Technetium-99m was incidentally detected in the two 
sites of the anterior neck. On ultrasound examination 
there were two hyperechoic and heterogeneous masses 
with calcifications placed in front of the hyoid bone 
and thyroid cartilage. Computerized tomography 
demonstrated massive hyoid bone and thyroid cartilage 
destruction. 
Conclusion: In patients with progressive sigmoid colon 
adenocarcinoma, destruction of the hyoid bone and 
thyroid cartilage could be suspected for metastases.
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metastases. According to the tumour board recommendation, 
a left hemicolectomy with regional lymph node removal was 
performed and the diagnosis of an invasive adenocarcinoma was 
confirmed [Dukes classification C; T3c N2 (6/9) L1 V1 R0]. 
The treatment was continued with four cycles of bevacizumab 
plus oxaliplatin-based chemotherapy, after which the patient 
underwent hepatic segmentectomy. Three months later, the 
chemotherapy was modified to FOLFOX regimen (Leucovorin 
Calcium, Fluorouracil, Oxaliplatin; 12 cycles) due to a CT-
verified recurrence of the liver metastases. After a follow-up of 
3 years, the chemotherapy regimen was changed to FOLFIRI 
(Leucovorin Calcium, Fluorouracil, Irinotecan Hydrochloride). 
Due to slow, continuous progression of the liver metastases, the 
chemotherapy protocol was changed to FOLFOX and XELOX 
(Capecitabine, Oxaliplatin) regimen. In this period, genetic 
analysis revealed a mutation of Gly12Asp in 12 codon of K-Ras 
gene. 
After the administration of the last chemotherapy cycle, the 
patient started to complain of severe pain in the left gluteal 
region and right arm. The significant elevation of serum levels 
of CEA (60 ng/mL) and CA 19-9 (255.5 U/mL) were detected. 
Osteolytic lesions within the left half of the sacrum and adjacent 
part of the iliac bone observed during CT examination indicated 
the presence of skeletal metastases and the patient underwent 
a bone scintigraphy. In addition to the increased accumulation 
of Technetium-99m in the left iliac bone, sacrum and the right 
proximal humerus, the radiopharmaceutical also accumulated at 
two sites in the anterior neck (Figure 1). Physical examination of 
the neck revealed two small, painless, palpable masses located 
anteriorly at the level of the hyoid bone and superior to the left 
lobe of the thyroid gland. When asked, the patient reported 
no significant symptoms. Ultrasound examination revealed a 
heterogeneous solid mass, with multiple small hyperechoic foci 
showing acustic shadowing and increased vascularization on 
colour Doppler. There was no cervical lymphadenopathy and 
the thyroid gland appeared normal. CT of the neck demonstrated 
enlargement of the body of the hyoid bone with massive 
osteolysis and cortical destruction (Figure 2a, 2c). The mass 
from the hyoid bone showed slight soft tissue extension toward 
the region of the vallecula and the epiglottis. Enlargement and 
destruction of the thyroid cartilage, predominantly of its left 
lamina, was also noted (Figure 2a-c). The airway lumen was not 
affected. There were no pathological changes in the adjacent 
structures of the neck. At this stage the patient’s performance 
status (PS) was scored as PS3. The multidisciplinary tumour 
board (MTB) proposed fine needle aspiration of the mass in 
FIG. 1. Bone scintigraphy shows accumulation of Tc-99m at the two 
sites of the anterior neck (arrows). Note also the accumulation of Tc-99m 
in the left iliac bone, sacrum and the right proximal humerus.
FIG. 2. Contrast-enhanced CT scans of the neck: (a) Enlargement 
and osteolyses of the hyoid bone (arrows) presented in a soft tissue 
and bone window (A-anterior, R-right); (b) Tumour mass in the thyroid 
cartilage with reactive sclerosis (arrows) presented in a soft tissue and 
bone window (A-anterior, R-right); (c) 3D reconstruction image of thyroid 
cartilage (arrow) and hyoid bone (asterisk) defects (A-anterior, H-head, 
P-posterior, F-foot).
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the hyoid bone. Even though the patient was fully informed 
about the suggested procedure, he still refused it. The MTB 
did not insist on performing the biopsy, bearing in mind that 
histopathological verification in this case would not influence 
the decision regarding choice of therapy. According to the MTB 
recommendation, the patient underwent palliative radiotherapy 
for the metastases in the sacrum. 
An informed consent was obtained from the patient.
DISCUSSION
Gastrointestinal adenocarcinoma is among the most common 
malignancies worldwide and one of the most common causes 
of cancer-related death. Although it commonly spreads to the 
regional lymph nodes, liver and lungs, it may also metastasize 
to unusual sites, such as paranasal sinuses and cryptorchid testis 
(5). Its metastases to the larynx and adjacent structures have 
been only occasionally reported (6). 
In the patient described in this case, the hyoid bone and 
thyroid cartilage lesions were detected simultaneously with 
osteolytic lesions in other skeletal sites. In the context of 
differential diagnosis we have considered diseases that may 
cause osteolytic lesions in the hyoid bone (i.e. primary bone 
tumours, multiple myeloma, secondary tumours from different 
primary malignancies). However, considering the status of 
primary malignant metastatic disease and elevated serum levels 
of tumour markers, the lesions in the hyoid bone and thyroid 
cartilage were highly suggestive of metastatic involvement by 
adenocarcinoma. This diagnosis was supported by the fact that 
unusual skeletal metastases of gastrointestinal adenocarcinoma 
more frequently occur in patients with disseminated disease 
than in patients without liver and/or lung involvement (7,8). 
Moreover, sigmoid tumours had the highest rate of bone 
metastasis in long-term follow-up in comparison to the right 
and left colon (8).
Although hyoid bone and thyroid cartilage involvement 
by sigmoid colon adenocarcinoma was highly suggestive, 
a biopsy was considered. However, the appropriateness of 
this procedure was brought into question. At the time of the 
bone metastases diagnosis, the patient had already developed 
multiple metastases to the liver and other skeletal sites. Severe 
pain due to the skeletal metastases contributed negatively to 
the patient’s general condition (low PS). Having in mind that 
K-Ras mutation is a predictive factor of survival in patients with 
colorectal cancer, this also contributed to the poor prognosis 
of the patient (9). In patients in a similar condition, palliative 
therapy had been suggested as a treatment of choice in order to 
improve the quality of life (6). Bearing in mind that the patient 
refused the biopsy as well as that the histological verification 
of masses in the neck would not influence the tumour board 
decision on the therapy, insisting on the procedure seemed 
unjustified. 
Metastases of the colorectal adenocarcinoma in this case 
probably involved the hyoid bone haematogenously. The 
spread along the branches of the superior laryngeal artery was 
previously suggested as the most likely pathway (10). Given 
that branches of the lingual artery also supply the hyoid bone, 
spreading through these vessels might also be possible. 
In summary, destruction of the hyoid bone and thyroid cartilage 
should be suspected for metastases in patients with progressive 
sigmoid colon adenocarcinoma. We suggest bone scintigraphy 
accompanied by CT examination in order to detect silent bone 
metastases.
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